Clinical trials
Completed Phase 1/2 Retinal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2019 | 4 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 3 |
| University of Sao Paulo | 2 |
| Astellas Institute for Regenerative Medicine | 1 |
| Lions Eye Institute, Perth, Western Australia | 1 |
| Nanoscope Therapeutics Inc. | 1 |
| ProQR Therapeutics | 1 |
| The Emmes Company, LLC | 1 |
| University of Nebraska | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Diseases | 11 |
| Eye Diseases | 4 |
| Macular Degeneration | 4 |
| Central Serous Chorioretinopathy | 3 |
| Diabetic Retinopathy | 2 |
| Retinal Degeneration | 2 |
| Retinitis Pigmentosa | 2 |
| Cardiovascular Diseases | 1 |
| Cerebral Palsy | 1 |
| Diabetic Angiopathies | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.